Business · 29/09/2010Updated: 10/17/2026 · 1 min read
FDA Amends Regulations for Human Drug and Biological Products Safety Reporting
Summary
The FDA is updating its rules to require more timely and useful safety information from human drug and biological product developers, aiming to improve public health and protect human trial participants.
Original source language: Federal Register — Health and Human ServicesOpen original release →